The involvement of epigenetics in vascular disease development.
Elia L, Condorelli G
Int J Biochem Cell Biol. 2018 Dec 10;107:27-31. doi: 10.1016/j.biocel.2018.12.005
Epigenetics and vascular diseases.
Stratton MS, Farina FM, Elia L
J Mol Cell Cardiol. 2019 Jun 15;133:148-163. doi: 10.1016/j.yjmcc.2019.06.010
miR-128-3p Is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Diseases.
Farina FM
Circ Res. 2020 Mar 27;126(12):e120-e135. doi: 10.1161/CIRCRESAHA.120.316489
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine.
Mingardi J
Neurobiol Stress. 2021 Aug 12;15:100381. doi: 10.1016/j.ynstr.2021.100381
rs41291957 controls miR-143 and miR-145 expression and impacts coronary artery disease risk.
Hall IF
EMBO Mol Med. 2021 Sep 22;13(10):e14060. doi: 10.15252/emmm.202114060
Aggravation of pulmonary fibrosis after knocking down the aryl hydrocarbon receptor in the insulin-like growth factor 1 receptor pathway.
Wu SM
Br J Pharmacol. 2022 Feb 28;179(13):3430-3451. doi: 10.1111/bph.15806
The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-κB pathway.
Farina FM
Eur Heart J. 43(43):4562-4576. doi: 10.1093/eurheartj/ehac097
Vascular malformation rupture in a patient affected by Costello syndrome.
Barbieri F
BMJ Case Rep. 2022 Dec 16;15(12)doi: 10.1136/bcr-2022-250948
Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells.
Correia DV
Blood. 2011 Jun 1;118(4):992-1001. doi: 10.1182/blood-2011-02-339135
Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication.
Hudspeth K
Blood. 2012 Mar 8;119(17):4013-6. doi: 10.1182/blood-2011-11-390153